CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

Cancer, rare disease dominate FDA approvals in H1 2026 as AstraZeneca, J&J clean up

Related Companies

Read the original article

Published by BioSpace on July 9, 2026 3:17 PM

Read Original